Dr. Rongsheng Jin's lab at UC Irvine focuses on understanding a type of bacterial toxin known as botulinum neurotoxins (BoNTs), which can cause a serious illness called botulism. The lab is particularly interested in a specific complex associated with these toxins, aiming to explore its structure and how it functions in order to develop new treatments for botulism and similar bacterial infections. They utilize advanced techniques to study how these toxins interact with proteins and receptors in the body, ultimately helping improve public health.

Devon A. Lawson's lab at the University of California-Irvine focuses on understanding the role of immune cells in brain metastasis, particularly in breast cancer. The lab investigates how brain resident macrophages called microglia can affect tumor growth and immune responses within the central nervous system. Their research aims to uncover mechanisms that could lead to new immunotherapeutic strategies for treating metastatic breast cancer patients.

Dr. Francesco Marangoni's lab at UC Irvine focuses on understanding how certain cancer treatments, specifically checkpoint blockade immunotherapy, can sometimes fail due to the body's immunosuppressive responses. By studying the role of immune cells called T regulatory cells and how different tumor environments affect them, the lab aims to identify strategies to enhance the effectiveness of these therapies. Their ultimate goal is to improve cancer treatment options for patients who currently see little benefit from existing therapies.

Dr. Steve A N Goldstein's lab at UC Irvine focuses on understanding how neutrophils, the white blood cells crucial for our immune response, contribute to lung injury during infections like COVID-19 and bacterial pneumonia. The lab investigates a specialized channel in these cells called hHv1, which plays a key role in driving inflammation. By developing inhibitors that target hHv1, the lab aims to find new treatments to prevent and mitigate acute lung injury and its severe form, ARDS.

Dr. Geoffrey Abbott's lab at UC Irvine focuses on understanding how certain small molecules can influence potassium channels in the brain. These channels are important for neuron function and play a role in conditions like epilepsy and addiction. By studying compounds derived from plants, the team aims to develop new treatments for these serious health issues. Their research combines advanced simulations, mutagenesis techniques, and mouse model testing to discover how these compounds work and how they can help in therapy.

Dr. Qin Yang's lab at the University of California-Irvine focuses on understanding how genetic factors contribute to type 2 diabetes, particularly through mechanisms like alternative polyadenylation. By studying specific genes and their regulation, the lab aims to uncover how these processes affect insulin production and function in pancreatic cells. This research not only elucidates basic biological mechanisms but also seeks to improve diabetes prevention strategies for individuals at genetic risk.

Dr. Shivashankar Othy's lab at UC Irvine focuses on understanding how specific immune cells, known as regulatory T cells, operate in the central nervous system during autoimmune diseases like multiple sclerosis. The research aims to uncover how these immune cells can help reduce inflammation and promote tissue repair. By employing advanced imaging techniques, the lab seeks to reveal new details about the interactions within the immune system that could lead to better treatments for autoimmune disorders.

Dr. Kevin T. Beier's research focuses on understanding how changes in the retrosplenial cortex, a specific brain region, contribute to the progression of Alzheimer's disease (AD). By studying both mouse models and human post-mortem samples, the lab aims to identify early indicators of AD and the molecular mechanisms involved. This research could lead to new therapeutic strategies to combat AD-related memory loss.

Dr. Lan Huang's lab focuses on understanding how proteins interact within cells, specifically looking at a system known as the ubiquitin-proteasome system that helps manage protein degradation. By advancing new technologies in mass spectrometry, the lab aims to unravel the complex networks of these protein interactions to shed light on their roles in diseases such as cancer and neurodegenerative disorders. This research could lead to new therapies that target these vital biological processes.

Professor Lisa Wagar's lab at UC Irvine focuses on understanding the immune responses to influenza viruses. Using a novel approach with human tonsil organoids, the lab investigates how different features of the host and the virus influence the effectiveness of immune responses. Their ultimate goal is to aid in the development of a universal influenza vaccine that could provide better protection against various influenza strains.